A Multicenter Double-Blind Randomized Placebo-Controlled Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/day, 600mg/day) as Adjunctive Therapy in Subjects With Partial Seizures with or without Secondary Generalization

  • Fakhoury, Toufic (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date5/5/0312/31/06